GI-ProBalance

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Lactobacillus plantarum, Quantity: 40.112 mg/g; Bifidobacterium lactis, Quantity: 28.169 mg/g; Lactobacillus acidophilus, Quantity: 7.3 mg/g; Streptococcus thermophilus, Quantity: 1.217 mg/g; Lactobacillus casei, Quantity: 1.3 mg/g; Bifidobacterium longum, Quantity: 3.267 mg/g; Bifidobacterium breve, Quantity: 1.975 mg/g; Lactobacillus rhamnosus, Quantity: 1 mg/g; fructooligosaccharides, Quantity: 520 mg/g; Acacia, Quantity: 237.66 mg/g; Larix arabinogalactan, Quantity: 1 mg/g; Tragacanth, Quantity: 1 mg/g; Aloe vera, Quantity: 1 mg/g (Equivalent: Aloe vera, Qty 415 mg/g; Equivalent: Hydroxyanthracene derivatives calculated as anhydrous barbaloin, Qty 0.01 ng/g)

Verfügbar ab:

Mannatech Australia Pty Ltd

Darreichungsform:

Powder

Zusammensetzung:

Excipient Ingredients: xylitol; silicon dioxide; Flavour

Verabreichungsweg:

Oral

Anwendungsgebiete:

Helps restore good/beneficial/friendly intestinal/gut/bowel flora ; Nourish good/beneficial/friendly intestinal flora

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2023-08-28